Skip to main content
Clinical Trials/TCTR20190712003
TCTR20190712003
Not yet recruiting
未知

Comparative outcomes of thromboprophylaxis between low molecular weight heparin (LMWH) and rivaroxaban in surgical gastrointestinal cancer patients

Ramathibodi hospital0 sites760 target enrollmentJuly 12, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
rivaroxaban &#44
Sponsor
Ramathibodi hospital
Enrollment
760
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 12, 2019
End Date
December 31, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • age \> 18 years
  • gastrointestinal cancer

Exclusion Criteria

  • previous venous thromboembolism
  • Preoperative DVT
  • Coadministration of anticoagulant medication
  • rivaroxaban drug allergy
  • active clinical bleeding
  • poor renal function (GFR \< 30\)
  • impair liver function (Child\-Pugh B and C)
  • History of heparin induced thrombocytopenia

Outcomes

Primary Outcomes

Not specified

Similar Trials